Keros Therapeutics, Inc. (KROS)

9.93 -0.23 (-2.26%) USD  |  NASDAQ  |  May 19, 14:20
More

Keros Therapeutics EBITDA Margin (TTM)

EBITDA Margin (TTM) Chart

View EBITDA Margin (TTM) for KROS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA Margin (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Margin (TTM) Range, Past 5 Years

View EBITDA Margin (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA Margin (TTM) Benchmarks

View EBITDA Margin (TTM) Benchmarks
Start Trial
Sarepta Therapeutics, Inc. Upgrade
PTC Therapeutics, Inc. Upgrade
Insmed, Inc. Upgrade
United Therapeutics Corp. Upgrade
Enanta Pharmaceuticals, Inc. Upgrade